RT Journal Article SR Electronic T1 Correlation of Airway Hyper-responsiveness With Obstructive Spirometric Indices and FEV1 > 90% of Predicted JF Respiratory Care FD American Association for Respiratory Care SP 565 OP 571 DO 10.4187/respcare.01244 VO 57 IS 4 A1 George H Kotti Maj USAF A1 David G Bell A1 Tokunbo Matthews A1 Pedro F Lucero A1 Michael J Morris YR 2012 UL http://rc.rcjournal.com/content/57/4/565.abstract AB BACKGROUND: Current published guidelines on spirometry interpretation suggest an elevated FVC and FEV1 > 100% of predicted with an obstructive ratio may represent a physiological variant. There is minimal evidence whether this finding can be indicative of symptomatic airways obstruction. METHODS: Pulmonary function testing databases for a 4-year period were retrospectively reviewed. All technically adequate spirometry studies were included, based on these criteria: FEV1 > 90% of predicted, and FEV1/FVC below the lower limit of normal, based on 95th percentile confidence intervals. Clinical indications for testing were noted. Testing for post-bronchodilator response, lung volumes, and methacholine challenge tests were reviewed for evidence of airway hyper-responsiveness (AHR). Comparisons were made between symptomatic versus asymptomatic individuals and FEV1 values less than or greater than 100% of predicted. RESULTS: A total of 280 studies were analyzed. During their clinical evaluation, 192 patients (69%) had post-bronchodilator spirometry recorded, 63 patients (23%) had lung volumes, and 36 patients (11%) completed methacholine challenge testing. Indications for spirometry included 193 symptomatic patients and 87 asymptomatic patients. Nearly 28% of patients with post-bronchodilator testing met criteria for AHR. No differences in AHR were found between the symptomatic and asymptomatic groups. The majority of patients (77%) with AHR had an FEV1 < 100%, when compared to patients with an FEV1 ≥ 100%. CONCLUSIONS: A normal FEV1 > 90% of predicted with obstructive indices may not represent a normal physiological variant, as 28% of patients were found to have underlying AHR. These findings suggest that clinicians should evaluate for AHR, especially in symptomatic patients, even if the FEV1 is > 90% of predicted.